1. Home
  2. LEXX vs PRZO Comparison

LEXX vs PRZO Comparison

Compare LEXX & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • PRZO
  • Stock Information
  • Founded
  • LEXX 2004
  • PRZO 2014
  • Country
  • LEXX Canada
  • PRZO Israel
  • Employees
  • LEXX N/A
  • PRZO N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • PRZO
  • Sector
  • LEXX Health Care
  • PRZO
  • Exchange
  • LEXX Nasdaq
  • PRZO Nasdaq
  • Market Cap
  • LEXX 19.6M
  • PRZO 20.1M
  • IPO Year
  • LEXX N/A
  • PRZO 2023
  • Fundamental
  • Price
  • LEXX $0.89
  • PRZO $1.46
  • Analyst Decision
  • LEXX Strong Buy
  • PRZO
  • Analyst Count
  • LEXX 1
  • PRZO 0
  • Target Price
  • LEXX $5.00
  • PRZO N/A
  • AVG Volume (30 Days)
  • LEXX 146.9K
  • PRZO 2.0M
  • Earning Date
  • LEXX 07-22-2025
  • PRZO 09-02-2025
  • Dividend Yield
  • LEXX N/A
  • PRZO N/A
  • EPS Growth
  • LEXX N/A
  • PRZO N/A
  • EPS
  • LEXX N/A
  • PRZO N/A
  • Revenue
  • LEXX $525,923.00
  • PRZO $932,154.00
  • Revenue This Year
  • LEXX $0.62
  • PRZO N/A
  • Revenue Next Year
  • LEXX $14.19
  • PRZO N/A
  • P/E Ratio
  • LEXX N/A
  • PRZO N/A
  • Revenue Growth
  • LEXX 29.95
  • PRZO 50.22
  • 52 Week Low
  • LEXX $0.82
  • PRZO $0.49
  • 52 Week High
  • LEXX $4.38
  • PRZO $3.16
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 41.23
  • PRZO 66.22
  • Support Level
  • LEXX $0.86
  • PRZO $1.37
  • Resistance Level
  • LEXX $1.05
  • PRZO $1.52
  • Average True Range (ATR)
  • LEXX 0.06
  • PRZO 0.09
  • MACD
  • LEXX 0.00
  • PRZO 0.02
  • Stochastic Oscillator
  • LEXX 30.70
  • PRZO 86.67

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the company applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.

Share on Social Networks: